Few studies to date have investigated the prognostic significanceof Ki67 expression as a continuous variable in breast cancer.This study aimed to evaluate the impact of Ki67 expression as adichotomous or continuous variable on outcomes in estrogenreceptor (ER)+ and human epidermal growth factor receptor 2(HER2)– breast cancer. This evidence concerns the gene ESR1 and breast cancer.